一种满足Sepsis-3标准且死亡率高度一致性的改良外科脓毒症模型
该研究将成年大鼠随机分为改良盲肠结扎穿孔(M-CLP)组、盲肠结扎穿孔(CLP)组和假手术组,术后24小时通过血压、行为学测试、组织病理学和血液检查评估重要器官功能,用酶联免疫吸附试验测定细胞因子水平,用流式细胞术评估T细胞抑制,并通过比较各组第1天至第14天重复实验的生存率评估模型稳定性。结果显示,M-CLP组满足Sepsis-3标准的大鼠比例高于CLP组(53.1% vs 21.9%,P=0.01),M-CLP组大鼠出现更严重的肝、肺、肾功能障碍,表现出更严重的免疫抑制和全身炎症,且模型动物生存率更稳定。作者认为该新型外科操作可使更多大鼠满足Sepsis-3标准,可能减少临床前脓毒症实验所需动物数量,该稳定的M-CLP模型可能有助于新疗法的开发。
要点
- 术后24小时,M-CLP组满足Sepsis-3标准的大鼠比例为53.1%,高于CLP组的21.9%(P=0.01)。
- M-CLP组大鼠出现更严重的肝、肺、肾功能障碍。
- 与CLP组相比,M-CLP组大鼠表现出更严重的免疫抑制和全身炎症,类似人类脓毒症。
- M-CLP组模型动物第1天至第14天的生存率更稳定,疾病发展和严重程度更一致。
- 作者认为该模型可能减少临床前脓毒症实验所需动物数量,并可能有助于新疗法开发。
适用人群与场景
- 成年大鼠,随机分为改良盲肠结扎穿孔(M-CLP)组、盲肠结扎穿孔(CLP)组和假手术组。
诊断标准与关键阈值
- Sepsis-3标准:原文提及满足Sepsis-3标准的大鼠比例,但未列出具体诊断条件或界值。
研究设计与关键结果
- 研究类型:动物实验;样本量:原文未报告各组具体动物数量;人群:成年大鼠;干预:改良盲肠结扎穿孔(M-CLP)vs 盲肠结扎穿孔(CLP)vs 假手术;主要终点:术后24小时满足Sepsis-3标准的比例,M-CLP组53.1% vs CLP组21.9%(P=0.01)。
- 次要终点:M-CLP组大鼠出现更严重的肝、肺、肾功能障碍;M-CLP组表现出更严重的免疫抑制和全身炎症;M-CLP组第1天至第14天重复实验的生存率更稳定。
证据类型、等级与局限
- 证据类型:动物实验(大鼠);证据等级:原文未给出;局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,该新型外科操作可使更多大鼠满足Sepsis-3标准,可能减少临床前脓毒症实验所需动物数量。
- 作者认为,该稳定的M-CLP模型可能有助于新疗法的开发。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Background : Cecal ligation and perforation (CLP) is currently considered the criterion standard model of sepsis; however, there are some deficiencies, such as low clinical relevance, inconsistency in severity grading, and an unknown proportion of CLP animals meeting the requirements of sepsis-3. Methods : Adult rats were randomly divided into the following three groups: modified CLP (M-CLP) group, CLP group, and sham group. The vital organ function of rats was evaluated 24 hours postoperatively by blood pressure, behavioral testing, histopathology, and blood test. Cytokine levels were determined by enzyme-linked immunosorbent assay, and T-cell suppression was assessed by flow cytometry. The stability of the model was evaluated by comparing the survival rates of repeated experiments in all groups from day 1 to day 14. Results : More rats in the M-CLP group met Sepsis-3 criteria than those in the CLP group 24 hours postoperatively (53.1% vs. 21.9%, P = 0.01). Rats in the M-CLP group developed more serious hepatic, pulmonary, and renal dysfunction. Similar to human sepsis, rats in the M-CLP group demonstrated more serious immunosuppression and systemic inflammation compared with the CLP group. In addition, disease development and severity, which was indicated by the stable survival rates of model animals, were more stable in the M-CLP group. Conclusions : More rats could meet Sepsis-3 criteria with this novel surgical procedure, which may reduce the number of animals needed in preclinical sepsis experiments. This stable M-CLP model may contribute to the development of new therapies.
参考来源
- Wang J, Liao L, Chen Y, et al. A MODIFIED SURGICAL SEPSIS MODEL SATISFYING SEPSIS-3 AND HAVING HIGH CONSISTENCY OF MORTALITY. Shock. 2023. PMID: 36821415. doi:10.1097/SHK.0000000000002096
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。